GP2 Novel GBA1 Webinar
Through the first-of-its-kind genome-wide study of 1,488 people with PD and 196,430 control volunteers, investigators identified a novel variant in GBA1 that increases the risk of Parkinson’s disease among people of African and African admixed populations.
On June 29th GP2 representatives presented the findings to the broader research community. Watch the recording below to hear:
Background on the primary contributing U.S. and Nigeria cohorts
Overview of the cross-cohort analysis
Next steps to expand on initial findings